RAPILIF D 4/0.5 MG CAPSULE 10

INTRODUCTION ABOUT RAPILIF D 4/0.5 TABLET

RAPILIF D 4/0.5 TABLET is used to manage signs and symptoms of Benign prostatic hyperplasia (BPH) in men with an enlarged prostate. RAPILIF D 4/0.5 TABLET is a combination of Dutasteride and Silodosin which belong to the group of medicines called 5-Alpha reductase inhibitors and Alpha blockers respectively. RAPILIF D 4/0.5 TABLET helps to improve symptoms and reduce the risk of acute urinary retention (complete blockage of urine flow) or the need for BPH-related surgery.

Before taking RAPILIF D 4/0.5 TABLET, inform your doctor if you have low blood pressure or liver, kidney, or heart disease. Women who are pregnant or can become pregnant should not handle the leaked RAPILIF D 4/0.5 TABLET, as it may cause serious harm to the baby. Men being manageed with RAPILIF D 4/0.5 TABLET should not donate blood for at least 6 months after their last dose, in order to inhibit the exposure of the medicine to pregnant women via blood transfusion.

Avoid consumption of alcohol while taking RAPILIF D 4/0.5 TABLET, as it may lower your blood pressure. RAPILIF D 4/0.5 TABLET is not recommended for use in children or adolescents below 18 years of age. The most common side effects of taking RAPILIF D 4/0.5 TABLET are orgasm with reduced or no semen, trouble getting or keeping an erection (impotence), a decrease in sex drive (libido), ejaculation problems (enlarged or painful breasts), dizziness, and low blood pressure while standing up from a sitting or lying position. Contact your doctor if any of the side effects worsen or persists for a longer duration.

USES OF RAPILIF D 4/0.5 TABLET

• Used to manage signs and symptoms of Benign prostatic hyperplasia (BPH) in men with an enlarged prostate

HOW RAPILIF D 4/0.5 TABLET WORKS

RAPILIF D 4/0.5 TABLET effectively reduces the symptoms of BPH, where Silodosin acts by relaxing the muscles surrounding the bladder and prostate by inhibiting the alpha-1 adrenergic receptors of the lower urinary tract. Dutasteride works by inhibiting the activity of an enzyme called 5-alpha reductase which is responsible for the conversion of testosterone into dihydrotestosterone. As a result, RAPILIF D 4/0.5 TABLET helps in the shrinkage of an enlarged prostate, making it easier for the urine to pass through and providing relief from symptomatic BPH.

DIRECTIONS FOR USE

Take RAPILIF D 4/0.5 TABLET as advised by your physician. Swallow RAPILIF D 4/0.5 TABLET with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending on your age and the severity of the condition.

SIDE EFFECTS OF RAPILIF D 4/0.5 TABLET